176 related articles for article (PubMed ID: 25075035)
1. Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Von Schulz-Hausmann SA; Schmeel LC; Schmeel FC; Schmidt-Wolf IG
Anticancer Res; 2014 Aug; 34(8):4101-8. PubMed ID: 25075035
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Wnt/beta-catenin pathway in multiple myeloma.
Schmeel LC; Schmeel FC; Kim Y; Endo T; Lu D; Schmidt-Wolf IG
Anticancer Res; 2013 Nov; 33(11):4719-26. PubMed ID: 24222106
[TBL] [Abstract][Full Text] [Related]
3. Effect of Wnt inhibitors in pancreatic cancer.
Wall I; Schmidt-Wolf IG
Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031
[TBL] [Abstract][Full Text] [Related]
4. Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
Koller CM; Kim Y; Schmidt-Wolf IG
Anticancer Res; 2013 Jun; 33(6):2435-40. PubMed ID: 23749892
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of cinnarizine against lymphoma and multiple myeloma.
Schmeel LC; Schmeel FC; Kim Y; Blaum-Feder S; Endo T; Schmidt-Wolf IG
Anticancer Res; 2015 Feb; 35(2):835-41. PubMed ID: 25667464
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
Kim Y; Schmidt M; Endo T; Lu D; Carson D; Schmidt-Wolf IG
In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681
[TBL] [Abstract][Full Text] [Related]
7. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
[TBL] [Abstract][Full Text] [Related]
8. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
9. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
[TBL] [Abstract][Full Text] [Related]
10. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
11. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.
Zhang X; Yang M; Shi H; Hu J; Wang Y; Sun Z; Xu S
Oncotarget; 2017 Mar; 8(12):19566-19576. PubMed ID: 28223537
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.
Chen Y; Huang Q; Zhou H; Wang Y; Hu X; Li T
Oncotarget; 2016 Aug; 7(31):50401-50416. PubMed ID: 27391060
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
Bi Y; Jiang Y; Li X; Hou G; Li K
J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
[TBL] [Abstract][Full Text] [Related]
14. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
[TBL] [Abstract][Full Text] [Related]
15. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
[TBL] [Abstract][Full Text] [Related]
16. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling.
Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J
Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma.
Cai F; Li J; Zhang Y; Huang S; Liu W; Zhuo W; Qiu C
BMC Cancer; 2024 Feb; 24(1):175. PubMed ID: 38317072
[TBL] [Abstract][Full Text] [Related]
18. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.
Ashihara E; Takada T; Maekawa T
Cancer Sci; 2015 Jun; 106(6):665-671. PubMed ID: 25788321
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/
Zhang YJ; Zhang L; Feng F; Cao QF
Dis Markers; 2021; 2021():2863856. PubMed ID: 34484467
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As
Li YL; Jin YF; Liu XX; Li HJ
Ren Fail; 2018 Nov; 40(1):331-339. PubMed ID: 29633893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
